Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline

NCT02256033 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Istradefylline

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]